The expression of p53 is deregulated in GBM, and studies have found that the expression of p53 and SLC7A11 is negatively correlated in glioma cells (81) and that p53 inhibits the expression of the SLC7A11 gene (82). The gene discussed is TP53; the disease is central nervous system cancer.